Keywords :
Diabetes Mellitus, Type 1/complications; Diabetic Retinopathy/complications/drug therapy; Hormones/therapeutic use; Humans; Male; Middle Aged; Octreotide/therapeutic use; Rosacea/complications/drug therapy; Treatment Outcome
Abstract :
[en] BACKGROUND: The precise pathomechanism of rosacea remains elusive. The disease commonly requires long-term treatments using topical or oral therapies. OBJECTIVE: This report presents incidental findings about the possible modulatory role of somatostatin in the outcome of rosacea. METHOD: Four patients presenting long-standing recalcitrant facial rosacea were treated with octreotide for diabetic retinopathy. RESULTS: Rosacea improved rapidly and even cleared without any recurrence in 3 of the patients. CONCLUSION: The beneficial effect might be attributed to inhibitory actions on the sebaceous gland, the neovascularization and/or on the inflammatory process.
Scopus citations®
without self-citations
15